Literature DB >> 18045116

Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS.

Shuji Sato1, Welkin Johnson.   

Abstract

Over the last two decades, use of SIV for experimental infection of Asian macaques has provided important leads in the quest for an AIDS vaccine, served as the genesis of recombinant SIV/HIV viruses (SHIV), and perhaps most importantly, helped establish or confirm biological relevance for a variety of hypotheses related to the host immune response to infection and the corresponding viral strategies for evading that response. The env genes of HIV-1 and SIV encode proteins bearing a high degree of structural similarity and sharing an identical suite of essential functions. The Env complexes formed by these proteins are present on the surface of virus-producing cells and virions, where they are the primary targets of the host neutralizing antibody response. In this review, we briefly describe the similarities between HIV-1 infection and SIV experimental models, then focus specifically on the use of the SIV/macaque model as a tool for understanding the humoral immune response to infection and resistance to antibody-mediated neutralization in HIV infection and AIDS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045116     DOI: 10.2174/157016207782418515

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  13 in total

1.  Immune mediators of rotavirus antigenemia clearance in mice.

Authors:  Glendie Marcelin; Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

2.  SIV infection duration largely determines broadening of neutralizing antibody response in macaques.

Authors:  Fan Wu; Ilnour Ourmanov; Andrea Kirmaier; Sivan Leviyang; Celia LaBranche; Jinghe Huang; Sonya Whitted; Kenta Matsuda; David Montefiori; Vanessa M Hirsch
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

3.  Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant.

Authors:  Susan W Barnett; Brian Burke; Yide Sun; Elaine Kan; Harold Legg; Ying Lian; Kristen Bost; Fengmin Zhou; Amanda Goodsell; Jan Zur Megede; John Polo; John Donnelly; Jeffrey Ulmer; Gillis R Otten; Christopher J Miller; Michael Vajdy; Indresh K Srivastava
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

4.  Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease.

Authors:  Roland C Zahn; Melisa D Rett; Ming Li; Haili Tang; Birgit Korioth-Schmitz; Harikrishnan Balachandran; Robert White; Sarah Pryputniewicz; Norman L Letvin; Amitinder Kaur; David C Montefiori; Angela Carville; Vanessa M Hirsch; Jonathan S Allan; Jörn E Schmitz
Journal:  Blood       Date:  2010-02-10       Impact factor: 22.113

5.  Flow cytometry based identification of simian immunodeficiency virus Env-specific B lymphocytes.

Authors:  Ismael Ben F Fofana; Arnaud D Colantonio; R Keith Reeves; Michelle A Connole; Jacqueline M Gillis; Laura R Hall; Shuji Sato; Craig R Audin; David T Evans; Hisatoshi Shida; R Paul Johnson; Welkin E Johnson
Journal:  J Immunol Methods       Date:  2011-06-13       Impact factor: 2.303

6.  Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation.

Authors:  Seth A Faith; Yingyun Wu; David Kuhrt; Jonathan D Steckbeck; Jodi K Craigo; Janice E Clements; Kelly Stefano Cole
Journal:  Virology       Date:  2010-02-11       Impact factor: 3.616

7.  Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes.

Authors:  Mohammed Asmal; Corinne Luedemann; Christy L Lavine; Linh V Mach; Harikrishnan Balachandran; Christie Brinkley; Thomas N Denny; Mark G Lewis; Hanne Anderson; Ranajit Pal; Devin Sok; Khoa Le; Matthias Pauthner; Beatrice H Hahn; George M Shaw; Michael S Seaman; Norman L Letvin; Dennis R Burton; Joseph G Sodroski; Barton F Haynes; Sampa Santra
Journal:  Virology       Date:  2014-11-22       Impact factor: 3.616

8.  The selection of low envelope glycoprotein reactivity to soluble CD4 and cold during simian-human immunodeficiency virus infection of rhesus macaques.

Authors:  Kathleen McGee; Hillel Haim; Birgit Korioth-Schmitz; Nicole Espy; Hassan Javanbakht; Norman Letvin; Joseph Sodroski
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

9.  High-Resolution Sequencing of Viral Populations during Early Simian Immunodeficiency Virus Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.

Authors:  Sergio Ita; Alison K Hill; Evan C Lam; Fay J Dufort; Xiao Yang; Ruchi Newman; Sivan Leviyang; Ismael B Fofana; Welkin E Johnson
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 10.  Monoclonal antibody-based therapies for microbial diseases.

Authors:  Carolyn Saylor; Ekaterina Dadachova; Arturo Casadevall
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.